Chen Shao-Ru, Dai Yan, Zhao Jing, Lin Ligen, Wang Yitao, Wang Ying
State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau, China.
Front Pharmacol. 2018 Feb 14;9:104. doi: 10.3389/fphar.2018.00104. eCollection 2018.
Triptolide and celastrol are predominantly active natural products isolated from the medicinal plant Hook F. These compounds exhibit similar pharmacological activities, including anti-cancer, anti-inflammation, anti-obesity, and anti-diabetic activities. Triptolide and celastrol also provide neuroprotection and prevent cardiovascular and metabolic diseases. However, toxicity restricts the further development of triptolide and celastrol. In this review, we comprehensively review therapeutic targets and mechanisms of action, and translational study of triptolide and celastrol. We systemically discuss the structure-activity-relationship of triptolide, celastrol, and their derivatives. Furthermore, we propose the use of structural derivatives, targeted therapy, and combination treatment as possible solutions to reduce toxicity and increase therapeutic window of these potent natural products from Hook F.
雷公藤甲素和雷公藤红素是从药用植物雷公藤中分离出的主要活性天然产物。这些化合物具有相似的药理活性,包括抗癌、抗炎、抗肥胖和抗糖尿病活性。雷公藤甲素和雷公藤红素还具有神经保护作用,并可预防心血管和代谢疾病。然而,毒性限制了雷公藤甲素和雷公藤红素的进一步开发。在本综述中,我们全面回顾了雷公藤甲素和雷公藤红素的治疗靶点和作用机制以及转化研究。我们系统地讨论了雷公藤甲素、雷公藤红素及其衍生物的构效关系。此外,我们提出使用结构衍生物、靶向治疗和联合治疗作为可能的解决方案,以降低这些来自雷公藤的强效天然产物的毒性并扩大其治疗窗。